Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
We recently reported that mice deficient in the programmed cell death-1 (PD-1) immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM), with production of high-titer autoantibodies against a heart-specific, 30-kDa protein. In this study, we purified the 30-kDa protein from heart extract and identified it as cardiac troponin I (cTnI), encoded by a gene in which mutations can cause familial hypertrophic cardiomyopathy (HCM). Administration of monoclonal antibodies to cTnI induced dilatation and dysfunction of hearts in wild-type mice. Monoclonal antibodies to cTnI stained the surface of cardiomyocytes and augmented the voltage-dependent L-type Ca2+ current of normal cardiomyocytes. These findings suggest that antibodies to cTnI induce heart dysfunction and dilatation by chronic stimulation of Ca2+ influx in cardiomyocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the cardiotoxicity of anti-cTnI autoantibodies has been reported in studies using BALB/c mice lacking PD-1 expression”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“PD-1-deficient BALB/c mice spontaneously developed autoimmune DCM mediated by anti-cTnI antibodies, and the pathology was transferable when wild-type mice were treated with these autoantibodies”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“suggesting a potential mechanism of ICI myocarditis.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“the cardiotoxicity of anti-cTnI antibodies has been reported in PD-1 -/- BALB/c mice”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“However, these autoantibodies are generally not disease-specific and may not consistently induce the disease phenotype in murine models, indicating their limitations as diagnostic and therapeutic targets. 57,92,97,191”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Self-citationThe Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Calcium tolerant ventricular myocytes prepared by preincubation in a ?KB medium?
Isenberg, G., & Klockner, U. (1982) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00584963 · Cited by 898
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-379 · Cited by 577
Cardiac myosin induces myocarditis in genetically predisposed mice.
Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., & Craig, S. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3630 · Cited by 526
Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
Shou, W., Aghdasi, B., Armstrong, D. L., Guo, Q., Bao, S., Charng, M.-J., Mathews, L. M., Schneider, M. D., Hamilton, S. L., & Matzuk, M. M. (1998) · Nature · doi:10.1038/35146 · Cited by 431
Cited by
Items 601–688 of 688
González-Rojas, A. D. V., González, M., Donis, J., Peterson, D. L., & Salmen, S. (2026) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2026.2684376 · Cited by 1
Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T-Cell Therapy
Naser, A., Morgan, A. A., & Zhang, L. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13080385 · Cited by 1
Wu, M., Sun, Y., Zhang, Y., Yang, Y.-C., He, Z.-X., Zhou, S., Wang, X., Xiao, H., Yu, M., Miao, C., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.074024 · Cited by 1
Autoimmune Murine Myocarditis and Immunomodulatory Interventions
Berger, C. T., & Eriksson, U. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_3 · Cited by 1
Assessing Individualized Medicine—The Example of Immunoadsorption
Marschall, P., Laslo, T., Hoffmann, W. U., Weitmann, K., & Fleßa, S. (2015) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-319-11719-5_14 · Cited by 1
Tanaka, Y., Morita, C. T., & Okamura, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55031-0_19 · Cited by 1
Self-citationT Cell Modulation: Anti-PD-1 Antibodies for the Treatment of Cancer
Ott, P. A., & Hodi, F. S. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-21167-1_10 · Cited by 1
Vaccination Against Breast Cancer and its Role in Prevention
Czerniecki, B. J., Nocera, N. F., Lowenfeld, L., Showalter, L., & Koski, G. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-27135-4_10 · Cited by 1
Cardiotoxicity from Immune Checkpoint Inhibitors: Myocarditis
Onderko, L. L., Bennett, E., & Francis, S. A. (2022) · Journal of Maine Medical Center · doi:10.46804/2641-2225.1104 · Cited by 1
Rotte, A., & Bhandaru, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-48066-4_12 · Cited by 2
Research Progress on Cardiotoxicity Associated with Immune Checkpoint Inhibitors
赵, 紫. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13102348 · Cited by 1
Salbach, C., Schlegel, P., Stroikova, V., Helmschrott, M., Mueller, A.-M., Weiß, C., Giannitsis, E., Frey, N., Raake, P. W. J., & Kaya, Z. (2024) · Transplantation · doi:10.1097/tp.0000000000005062 · Cited by 1
Tsai, K. K., Chang, A. Y., Abouzeid, C. M., Aras, M. A., Fang, Q., Bibby, D., Haghighat, L., Hilton, J. F., DAUD, A. I., & Schiller, N. B. (2025) · Echocardiography · doi:10.1111/echo.70158 · Cited by 1
B7 Family Molecules in the Placenta
Petroff, M. G. (2007) · Springer eBooks · doi:10.1007/0-387-34944-8_15 · Cited by 1
Déviation de l’auto-immunité chez la souris NOD invalidée pour la voie ICOS/ICOSL
Briet, C. (2012) · theses.fr (ABES) · doi:10.70675/14d271c3z64dcz483dz86afz366c43a0eae6 · Cited by 1
Models of autoimmune heart disease
Eriksson, U., Köpf, M., Afanasyeva, M., & Penninger, J. M. (2004) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2004.11.015 · Cited by 1
Molecular genetics of dilated cardiomyopathy in the Dobermann dog
Stabej, P. L. Q. (2005) · Repository of the University of Ljubljana (University of Ljubljana) · Cited by 1
Gupta, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.018 · Cited by 1
Keeping the Failing Heart in Check
Zheng, W., & Tang, W. H. W. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.07.009 · Cited by 1
Co-stimulation Regulation of Immune Tolerance and Autoimmunity
Dong, C., Nurieva, R., & Martín‐Orozco, N. (2007) · Springer eBooks · doi:10.1007/978-0-387-36003-4_7 · Cited by 1
Checkpoint Inhibitor–Associated Autoimmunity: What a Rheumatologist Needs to Know
Ghosh, N., & Bass, A. R. (2019) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001209 · Cited by 2
Pathogenic relevance of autoantibodies in dilated cardiomyopathy
Jahns, R., Boivin, V., Ertl, G., & Lohse, M. J. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_7
Immunoadsorption in dilated cardiomyopathy patients
Felix, S. B., & Staudt, A. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_15
Fábry, Z., Reinke, E. K., Zozulya, A. L., Sándor, M., & Bechmann, I. (2007) · Springer eBooks · doi:10.1007/978-0-387-30398-7_8
Envolvimento de sinais co-estimulatórios na progressão das doenças periodontais humanas
Figueira, E. A. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.25.2007.tde-16102008-094908 · Cited by 1
Modulação da resposta imune durante o desenvolvimento de carcinoma espinocelular
Belai, E. B. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.25.2011.tde-18012012-143731 · Cited by 1
Jahns, R., Deubner, N., Biovin, V., Alida, L. P., Stephan, B., Fu, M., Martin, J. W., & Ertl, G. (2011) · InTech eBooks · doi:10.5772/24986
Isik, A. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-15577
T-cell costimulation blockade in immunologic diseases: role of CD28 family members
Clay, B. S., & Sperling, A. I. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.3.383
Hammer, E., Phong, T. Q., Steil, L., Salazar, M. G., Scharf, C., Kandolf, R., Felix, S. B., Kroemer, H. K., Klingel, K., & Völker, U. (2012) · Journal of Integrated OMICS · doi:10.5584/jiomics.v2i2.96
Molecular characterization of virus-induced autoantibody responses
Krebs, P., Ludewig, B., Metters, Türeci, Ö., & Şahin, U. (2004) · Cancer Cell International · doi:10.1186/1475-2867-4-s1-s59
Envolvimento de sinais coestimulatórios na periodontite apical crônica em humanos
Delgado, R. J. R. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.25.2011.tde-14122011-092305 · Cited by 1
Relevance of antibodies targeting the β1-adrenergic receptor for renal function
von Antikörpern, R. (2014)
Immune System Alterations in Acute Heart Failure
Adams, K. F., & Ng, T. M. H. (2008) · Springer eBooks · doi:10.1007/978-1-84628-782-4_14
Immune Checkpoint Inhibition in Renal Cell Carcinoma
Mahoney, K. M., Harshman, L. C., Seery, V. J., & Drake, C. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_16
Immunoadsorption in Dilated Cardiomyopathy
Felix, S. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_20
Enhancement of tolerogenic or immunostimulatory potential of dendritic cells for therapeutic goals
Hanif, J. K. (2011) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/47574
Jereza, N. A. (2016) · UWE Research Repository (UWE Bristol)
Post-Genomic Appraisal of Myocarditis
Marín-García, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00011-1
Reversing T Cell Dysfunction for Tumor Immunotherapy
Kane, L., & Delgoffe, G. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-29827-6_5
Mechanisms of Immune Escape in Cancer
Hara, H. (2016) · Journal of Nihon University Medical Association · doi:10.4264/numa.75.4_152
Does extracellular cardiac troponin I play a pathogenic role independently of autoantibodies?
Redwood, C. S. (2016) · Clinical Science · doi:10.1042/cs20160493
Development of PD-1 Inhibition in Cancer Therapy: Dramatic Advances for Medical Oncology
Hayashi, H., & Nakagawa, K. (2019) · TRENDS IN THE SCIENCES · doi:10.5363/tits.24.2_25
PD-1 Research: History and Future Perspectives
Okazaki, T. (2019) · TRENDS IN THE SCIENCES · doi:10.5363/tits.24.2_8
Self-citationИммунозависимые побочные эффекты, ассоциированные с иммунотерапией рака
Golovach, I. Y., & Yehudіna, Y. D. (2019) · Practical oncology · doi:10.22141/2663-3272.2.3.2019.186471
Organ-Specific Autoimmune Myocarditis
Caforio, A. L. P., Cheng, C., Seguso, M., Gallo, N., Marcolongo, R., & Iliceto, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_10 · Cited by 1
Mechanismen der Kardiotoxizität onkologischer Therapien
Lehmann, L., & Fröhling, S. (2021) · Wiener klinisches Magazin · doi:10.1007/s00740-021-00381-5
Cardivascular Toxicities of Immunotherapy
Gandhi, S., Gupta, A., Vachhani, P. J., Puzanov, I. J., & Ernstoff, M. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-67241-2.00023-9
Cardiovascular Oncologic Emergencies
Nafee, T., Debs, D., Planek, M. I. C., Zimmerman, A., Charlton, T., Dimza, M., Murphy, A. C., Dobbin, S. J. H., Lang, N. N., Tyebally, S. M., et al. (2021) · Springer eBooks · doi:10.1007/978-3-030-67123-5_21
Proverbs-Singh, T. A., Wolchok, J. D., & Snyder, A. (2018) · Wiley eBooks · doi:10.1002/9781118684535.ch4
ウイルス性心筋炎および心筋梗塞における心臓リンパ管の役割について(8. 炎症性心疾患-最近の進歩と今後の展望, <特集>第69回日本循環器学会学術集会)
亮介, 西., 肇, 久., & 昭, 松. (2005) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.13.2_305
元三, 竹., & 久義, 藤. (2005) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.13.1_103
希, 伊., 広紀, 辻., 小野, 聡., & 秀樹, 上. (2019) · The Japanese Journal of SURGICAL METABOLISM and NUTRITION · doi:10.11638/jssmn.53.5_267
Management of Patients with Cardiac Toxicity: The Point of View of the Oncologist
Zagami, P., Morganti, S., Tarantino, P., & Curigliano, G. (2022) · Current clinical pathology · doi:10.1007/978-3-030-97744-3_9
Mizui, M., & Tsokos, G. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00030-7
Weiss, S. A., Djureinovic, D., Jessel, S., Krykbaeva, I., Zhang, L., Jilaveanu, L. B., Ralabate, A. L., Johnson, B. A., Levit, N. S., Anderson, G., et al. (2023) · doi:10.1158/1078-0432.22480424
Az immunellenőrzőpont-gátló onkológiai terápiák kardiovaszkuláris mellékhatásai
Drobni, Z. D., Zoltán Varga, V., Pozsonyi, Z., Szűcs, A., Becker, D. J., Vágó, H., & Merkely, B. P. (2023) · Cardiologia Hungarica · doi:10.26430/chungarica.2023.53.2.95 · Cited by 1
Generation and Immuno-inflammatory Checkpoints in Oral Cavity Cancers
Hatamnezhad, L. S. (2023) · Biomedical Research Bulletin · doi:10.34172/biomedrb.2023.22
Myocarditis and dilated cardiomyopathy
Stroikova, V., Salbach, C., & Kaya, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00032-1
Xu, S., Sonkawade, S. D., Karthikeyan, B., Karambizi, V.-G., Kulkarni, P. S., Nepali, S., Pokharel, S., & Sharma, U. C. (2025) · Cardio-Oncology · doi:10.1186/s40959-025-00315-8
Sgodzai, M., Klöster, K., Karakaya, H., Didhevar, P., Horstkemper, L., Rilke, N., Demir, S., Klimas, R., Pedreiturria, X., Blusch, A., et al. (2025) · Brain · doi:10.1093/brain/awaf304
Cardiac Dysfunction and Heart Failure Caused by Cancer Therapy-Induced Cardiotoxicity
Șoșdean, R., Giuchici, S., Ionică, L. N., Furdui-Lința, A. V., Sturza, A., Muntean, D. M., Lighezan, D., & Bolli, R. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_2
Rowe, S. J., McKubre, K., Janssens, K., Mitchell, A. M., Cullen, O., Spencer, L. W., Bekhuis, Y., D’Ambrosio, P., Newcomb, K., Paratz, E. D., et al. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag249.376
Bai, W., Maimaiti, M., Zhang, X., Zhu, X., Saimi, M., & Wulasihan, M. (2025) · Medicine · doi:10.1097/md.0000000000046309
Jia, X.-H., Geng, L.-Y., Jiang, P.-P., Xu, H., Nan, K.-J., Yao, Y., Jiang, L.-L., Sun, H., Qin, T.-J., & Guo, H. (2020) · Figshare · doi:10.6084/m9.figshare.13468451
Jia, X.-H., Geng, L.-Y., Jiang, P.-P., Xu, H., Nan, K.-J., Yao, Y., Jiang, L.-L., Sun, H., Qin, T.-J., & Guo, H. (2020) · Figshare · doi:10.6084/m9.figshare.13468447
New approach for transgenic T-cell receptor experimental autoimmune neuritis models in mice
Sgodzai, M. (2025) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · doi:10.13154/294-13694
Inhibitory receptor agonists: Emerging strategies in immune modulation
Adam, K. R., Suhail, A., Kuchroo, V. K., & Vignali, D. A. A. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20241217 · Cited by 1
Anquetil, C. (2021) · theses.fr (ABES) · doi:10.70675/dce475d2z4b83z4647z85aczea2eb971762b
Fang, H., Guo, B., Sun, Y., Jin, W., & Wang, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1845366
Liu, T., Meng, X., Li, Y., Mi, F., Yang, X., & Sha, S. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2694884
Cardiotoxicity of pembrolizumab therapy: narrative review
Virk, J. (2026) · Exploration of Cardiology · doi:10.37349/ec.2026.1012117
Zhu, Z., Sheng, Y., Chang, Y., Chang, Y., Xu, M., Zhou, W., Wang, W., Liao, Q., Shi, Z., Zhang, M., et al. (2026) · MedComm · doi:10.1002/mco2.70940
Shao, Y., Saaoud, F., Issa, M., Xu, K., Lu, Y., Hung, S., Liu, J., Yuan, B., Wei, J., Wu, S., et al. (2026) · Barrier Immunity · doi:10.1002/dni2.70016
Immunotherapy-Related Cardiac Arrythmias: Incidence, Pathobiology, Risk Factors and Management
Agarwal, M. A., Mohammad, F., Agdamag, A. C., Guha, A., Yang, E. H., Shafei, F., Ismail, G., Khan, H., Zaki, A. A., Grobmeyer, S., et al. (2026) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-026-00792-1
Junes, H., Vinje, V., Heck, S. L., Gulati, G., Omland, T., & Wittfooth, S. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.122893
Immune Responses in Checkpoint Inhibitor–Associated Cardiovascular Immune–Related Adverse Events
Reynolds, K. L., Villani, A., Drobni, Z. D., Neilan, T. G., Zhu, H., Wagner, N. S., Balko, J. M., Fankhauser, R., Moslehi, J. J., Palaskas, N. L., et al. (2026) · JACC CardioOncology · doi:10.1016/j.jaccao.2026.09.005
Schiffer, D., Afshar, B., Grosser, D., Pet, J., Schmidbauer, L., Bauser, M., Ramos, G., Boivin‐Jahns, V., Jahns, R., Frantz, S., et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06808-3
Overcoming Immune Suppression: Therapeutic Strategies Targeting T-Cell Function in Cancer
Weber, J. S. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_16
Crystal structure of the N-myristoylated lipopeptide-bound MHC class I complex
Morita, D., Yamamoto, Y., Mizutani, T., Ishikawa, T., Suzuki, J., Igarashi, T., Mori, N., Shiina, T., Inoko, H., Fujita, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10356 · Cited by 20
Self-citation
Metadata
- Authors
- Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., & Honjo, T.
- Affiliations
- Kyoto University (JP)
- Mie University (JP)
- Corresponding author
- Honjo, Tasuku
- ORCID
- Venue
- Nature Medicine
- Published
- 2003-11-02
- Volume
- 9
- Issue
- 12
- Pages
- 1477-1483
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2140419562
- Semantic Scholar
- 8b8bf12ad1a303d244e325c58410b356c4ed2945
- Cited by
- 689
- References
- 38
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 44 · 2023: 36 · 2022: 49 · 2021: 49 · 2020: 47 · 2019: 46 · 2018: 28 · 2017: 30 · 2016: 32 · 2015: 19 · 2014: 20 · 2013: 22 · 2012: 16
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- cardiac troponin I, autoantibodies, dilated cardiomyopathy, PD-1 deficiency, autoimmune cardiomyopathy, familial hypertrophic cardiomyopathy, L-type calcium current, cardiac dysfunction, monoclonal antibodies
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Surface, Autoantibodies, Base Sequence, Cardiomyopathy, Dilated, Humans, Mice, Inbred A, Mice, Inbred BALB C, Mice, Nude, Antigens, CD, Rats, Wistar, DNA, Complementary, Mice, Knockout, Troponin I, Calcium Signaling, Myocytes, Cardiac, Apoptosis Regulatory Proteins, Mice, Rats, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.